OEDEMA and Ambien


OEDEMA Symptoms and Causes

Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.

Causes of edema include

  • Eating too much salt
  • Sunburn
  • Heart failure
  • Kidney disease
  • Liver problems from cirrhosis
  • Pregnancy
  • Problems with lymph nodes, especially after mastectomy
  • Some medicines
  • Standing or walking a lot when the weather is warm

To keep swelling down, your health care provider may recommend keeping your legs raised when sitting, wearing support stockings, limiting how much salt you eat, or taking a medicine called a diuretic - also called a water pill.

Check out the latest treatments for OEDEMA

OEDEMA treatment research studies

Ambien clinical trials, surveys and public health registries

Find Drug Side Effect reports

Ambien Side Effects

Amnesia (650)
Somnambulism (372)
Road Traffic Accident (273)
Fall (233)
Abnormal Behaviour (217)
Impaired Driving Ability (191)
Abnormal Sleep-related Event (189)
Confusional State (153)
Hallucination (147)
Anxiety (127)
Depression (123)
Loss Of Consciousness (113)
Dizziness (106)
Sleep Walking (102)
Insomnia (101)
Pain (97)
Headache (92)
Feeling Abnormal (91)
Somnolence (89)
Contusion (85)
Memory Impairment (85)
Fatigue (83)
Nausea (82)
Aggression (80)
Back Pain (73)
Asthenia (67)
Eating Disorder (67)
Suicidal Ideation (66)
Hallucination, Visual (64)
Disorientation (63)
Chest Pain (61)
Dyspnoea (60)
Diarrhoea (54)
Vomiting (52)
Arthralgia (52)
Completed Suicide (51)
Overdose (51)
Balance Disorder (51)
Agitation (50)
Sleep-related Eating Disorder (46)
Nightmare (45)
Malaise (43)
Gait Disturbance (43)
Sleep Talking (42)
Head Injury (40)
Intentional Overdose (38)
Weight Increased (38)
Injury (36)
Incorrect Dose Administered (35)
Convulsion (35)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

Ambien helped me get through all those sleepless nights. I'm happy with this product that I got at

Have you tried Agrisept-L?

Have you tried Bactine spray and Triple Antibiotic Ointment and Robaxin and Nystatin and Fluconazole?

Have you tried Cogentin?

Have you tried physical therapy?

I am a 49 year old female who was presecribed Ambien 10mg for insomnia. I took the medication for two years. I developed parathesias throughout my body, mostly in my face; extreme muscle pain to the point of rigidity. My symptoms

I have been taking ambien for only ten days for insomnia prescribed by my doctor and had to stop because of an array of nasty side effects which I have organized into the following list: Ambien side effects I experienced: Shakes (Tremors) Headac

I have taken 5mg of Ambien for years on and off. it really has helped me. Keep the dose low.

I would like to know if taking ambien cr6,25 can make my tinnitus worse

Left eye only. Upper eyelid is droopy. Lower eyelid is swollen. Eyeball is protruding. Slight Graves. Dentist narrowed my teeth at gumline, I guess he did not like.

Dear sir I want to inform that in using gliclazid in a patient with mild degree of hepatosplenomegally diagnosed as mild liver cirrhosis the patient state is detorated and develop mild ascites and moderate to severe lower limbe oedema

Does Inipomp cause oedema

Female 39 years old from Denmark. Was treated with Octostim as a test. After drug was administred i experience this: <span style='font-weight: bold;'><a href='' rel='

I have faced moderate olmesartan side effect with pedal oedema

I have long term liver disease and ascites due to alcohol excess when I was younger. My doc has prescribed Aldactone 25 (three a day because I also have high blood pressure) but my oedema seems to be getting worse instead of better. I have noticed

I recently starting using Clobetasol for a skin complaint and suffered from eyelid oedema. One eye was worse than the other, but both were affected. I have since reduced my use of this drug and the swelling is now subsiding.

I used this drug in 4 injectionsof 7 ml each, 2 each month because we were afraid that i am going to deliver my twins before the due date. But after 3 months from the last injection and i still have a face oedema, knowing that i stopped eating salt d

I was prescribed Avelon for sinobronchitis. On the first night I developed facial oedema and terrible itch all over my body. Subsequently I would take it after taking aerius, an antihistamine. After 5 or so days of treatment, my legs began

Is pedal oedema is a side effect of olmesartan

My legs and feet have quite severe oedema for the past few days, and i feel very sluggish. Could these be side effects of Norspan 20. have been using the patches for about a month for severe back, knee and hip pain.

OEDEMA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care Patients
Conditions: Laryngeal Edema;   Acute Respiratory Failure Requiring Reintubation
Outcome Measures: Performance of laryngeal ultrasonography in predicting major post extubation laryngeal edema in intensive care patients.;   Performance of laryngeal ultrasonography in predicting post-extubation stridor in intensive care patients.;   Frequency of major post-extubation laryngeal edema and post-extubation stridor;   Risk factors of major post-extubation laryngeal edema in intensive care unit;   Evolution of ultrasonic parameters with corticotherapy after reintubation for a major post-extubation laryngeal edema;   Evaluation of impact of major post-extubation laryngeal edema occurence on mechanical ventilation duration, hospitalization duration and mortality in intensive care unit;   Inter-observer reproductibility of ultrasound scanning and ultrasonic air-leak volume measurement
2 Not yet recruiting Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Conditions: Macular Edema;   Cystoid Macular Edema;   Uveal Melanoma;   Radiation Maculopathy;   Radiation Retinopathy
Interventions: Drug: Ozurdex;   Drug: Bevacizumab
Outcome Measures: Proportion of eyes showing >=2 lines of improvement in best-corrected visual acuity;   Change in central subfield retinal thickness;   Development of glaucoma;   Development of cataract;   Development of retinal detachment;   Development of vitreous hemorrhage
3 Recruiting Intraocular Bevacizumab Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Bevacizumab (Avastin);   Drug: Triamcinolone;   Drug: Sham;   Procedure: Lucentis
Outcome Measures: Efficacy of the treatment assessed with visual acuity measured by ETDRS charts and central retinal thickness as measured by standard Optical Coherence Tomography (OCT);   To explore the structural mechanisms of the effect on diabetic macular edema as assessed by fluorescein angiography and ultra high-resolution optical coherence tomography. To observe the changes in retinal function a microperimetry is assessed.
4 Recruiting Does NMES Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?
Condition: Oedema
Intervention: Device: Duo-STIM neuromuscular electrical stimulator
Outcome Measures: Oedema Reduction;   Joint Mobility;   Skin Oxygenation
5 Recruiting Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
Conditions: Diabetes;   Diabetic Macular Oedema;   Diabetic Macular Edema;   Diabetic Retinopathy
Interventions: Drug: Avastin (Bevacizumab);   Drug: Ozurdex (dexamethasone)
Outcome Measures: Proportion of eyes that have central macular thickness <300 microns 6 months after switching;   Mean change in central macular thickness (CMT) as measured by OCT.
6 Unknown  Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Conditions: Corneal Edema;   Visual Acuity
Interventions: Drug: Brimonidine Tartrate 0.2%;   Drug: Timolol maleate 0.5%
Outcome Measures: central corneal thickness in micrometer;   grading of corneal edema (1-3)
7 Not yet recruiting OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Conditions: Diabetes;   Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Device: OCT imaging
Outcome Measures: Rates of retina care for patients with diabetic macular edema;   Retinal referral rates for patients with DME;   Rates of retinal treatment for patients with DME;   Rates of retinal treatment over 1 year for patients with DME
8 Recruiting Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic Cancer
Condition: Gynecologic Cancer
Intervention: Other: Pelvic and lower extremity exercise
Outcome Measures: Change in lower extremity edema-related symptoms after pelvic and lower extremities exercise;   the compliance rate of management guidelines for lower extremity edema, the performance rate for pelvic and lower extremity exercise
9 Unknown  Power Spectral Analysis of Breath Sound in Pulmonary Edema
Condition: Pulmonary Edema
Outcome Measure:
10 Unknown  Triple Therapy for Diffuse Diabetic Macular Edema
Condition: Diffuse Diabetic Macular Edema
Intervention: Procedure: Triple therapy for diffuse diabetic macular edema
Outcome Measures: Best-corrected visual acuity (BCVA) and central macular thickness (CMT);   Presence of vitreomacular traction or epimacular membrane, grade of DR, patients age, HbA1c level, BMI, systemic hypertension
11 Not yet recruiting A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Intervention: Drug: Teprotumumab
Outcome Measure: Safety of RV001in subjects with Diabetic Macular Edema
12 Recruiting Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
Condition: Diabetic Macular Edema
Outcome Measures: Central Retinal Thickness (Change from screening);   Presence (and location) of cysts in the retinal layers (change from screening);   Presence of OCT diffuse macular edema (without cyst formation) (change from screening);   Presence of neurosensorial retinal detachment. (change from screening);   Degree of integrity of the photoreceptors in the inner/outer segments layer in the 1 mm centered in the fovea (change from screening);   Presence and extension of capillary occlusion (change from screening);   Area of macular leakage (intraretinal fluid volume and retinal thickness) (change frmo screening);   Best Corrected Visual Acuity (BCVA) (Change from screening);   Central Retinal Thickness (change from screening);   Area of macular leakage (intraretinal fluid volume and retinal thickness) (change from screening);   Best Corrected Visual Acuity (change from screening)
13 Recruiting A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Condition: Macular Edema, Diabetic
Interventions: Drug: Ranibizumab;   Drug: Placebo;   Drug: PF-04634817;   Drug: Masked Sham Therapy
Outcome Measures: Mean Change from Baseline in the Best Corrected Visual Acuity Score;   Proportion of participants gaining 15 ETDRS letters in BCVA from baseline;   Mean changes in central subfield retinal thickness from baseline as assessed by optical coherence tomography (OCT);   Mean changes in the area of fluorescein leakage from baseline by scheduled study visit as assessed by fluorescein angiography (FA);   Mean change in steps of diabetic retinopathy (ETDRS severity scale) from baseline as assessed by digital fundus photography (FP);   The systemic exposure of PF-04634817 in participants with diabetes and macular edema
14 Unknown  Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome
Condition: Bone Marrow Edema
Interventions: Drug: Aclasta;   Drug: Placebo
Outcome Measures: Reduction of the Edema area;   Reduction of pain (VAS);   Quality of life (Qualeffo-41 questionnaire - Quality of life questionnaire of the European Foundation for Osteoporosis);   Subjective estimation of medical condition (PDI);   Number of additional medicinal visits;   Number of days of illness;   Number of Participants with Adverse Events as a Measure of Safety and Tolerability
15 Recruiting Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome (ARDS);   Hypovolemia;   Pulmonary Edema
Intervention: Drug: hydroxyethyl starch
Outcome Measures: Rate of alveolar fluid clearance;   Extra-vascular lung water;   Pulmonary vascular permeability index;   Global enddiastolic volume index;   mean arterial pressure;   cardiac output;   pulse pressure variation;   stroke volume variation;   central venous venous oxygenation;   central venous pressure;   PaO2;   lung compliance;   airways resistance;   lung injury score;   Plasma levels of sRAGE;   Alveolar levels of sRAGE;   Brain natriuretic peptide levels;   Plasma osmolarity;   Oncotic pressure;   Electrical impedance tomography;   Mortality
16 Unknown  Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Conditions: Diabetic Retinopathy;   Macular Edema
Intervention: Drug: Ranibizumab
Outcome Measures: Mean change in Early Treatment for Diabetic Retinopathy Study (ETDRS) eye chart vision.;   Mean number of injections.;   Mean change in spectral domain optical coherence tomography (SD-OCT) central foveal thickness (CFT).;   Percentage of patients with best corrected visual acuity (BCVA) Snellen-equivalent of 20/40 or better.;   Percentage of patients anatomically "dry.";   Number of participants with adverse events as a measure of safety and tolerability.
17 Recruiting Prevention and Treatment of Immersion Pulmonary Edema
Conditions: Immersion Pulmonary Edema (IPE);   Swimming Induced Pulmonary Edema (SIPE)
Intervention: Drug: Sildenafil
Outcome Measure: Pulmonary artery pressure during cold water immersion
18 Not yet recruiting Cold Magnesium Sulfate Solution for Perineal Swelling Following Vaginal Delivery
Conditions: Vaginal Delivery;   Perineal Swelling;   Perineal Pain
Interventions: Other: Cold pads soaked in Magnesium sulfate solution;   Other: Cold pads soaked in water
Outcome Measures: Reduction in the level of perineal pain;   Reduction in perineal swelling;   Reduction in hemorrhoids pain and swelling
19 Recruiting The Intraocular Pressure Measured by Different Tonometers in Corneal Edema
Conditions: Intraocular Pressure;   Corneal Edema
Intervention: Other: Intraocular pressure measurement
Outcome Measures: Intraocular pressure;   Relationship between the central corneal thickness and intraocular pressure measured by each tonometer
20 Recruiting Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
Conditions: Macular Edema, Cystoid;   Vision Disorders;   Diabetic Macular Edema;   Cystoid Macular Edema Following Cataract Surgery;   Cataract
Interventions: Drug: Dexamethasone Drug delivery system (Ozurdex);   Procedure: Cataract surgery
Outcome Measures: change in the central macular thickness;   Change in the visual acuity